Free Newsletter
Ratiopharm plots 600 layoffs
Free newsletter via e-mail
Tools
Ratiopharm plans to cut 600 jobs over the next 18 months, as it seeks to reduce its annual operating costs by approximately €100 million. The move will affect one in nine of the company's global workforce of 5,400 staff. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: